Cargando…

Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma

BACKGROUND AND OBJECTIVES: The present study of survival rate of patients with non-small cell carcinoma (NSCLC) compared the efficiency of Cox semi-parametric vs. parametric models in determination of influencing factors. METHODS: In this retrospective cohort study, data were gathered from 190 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaksar, Elahe, Askarishahi, Mohsen, Hekmatimoghaddam, Seyedhossein, Vahedian-Ardakani, Hassanali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980899/
https://www.ncbi.nlm.nih.gov/pubmed/29286608
http://dx.doi.org/10.22034/APJCP.2017.18.12.3389
Descripción
Sumario:BACKGROUND AND OBJECTIVES: The present study of survival rate of patients with non-small cell carcinoma (NSCLC) compared the efficiency of Cox semi-parametric vs. parametric models in determination of influencing factors. METHODS: In this retrospective cohort study, data were gathered from 190 patients with a confirmed diagnosis of NSCLC referred to Shahid Sadoughi and Shohadaye Kargar Hospitals in Yazd, Iran during 2005 to 2014. To identify and compare factors influencing the survival rate, a Cox semi-parametric model was fitted to the data. Data analysis was performed using the R software version R3.3.1, and the significance level was set at 0.05. RESULTS: The average age was 64.5 years. About 40% of patients had stage 4 disease. The median survival was 8 months. After comparing the models, the more efficient was the log-normal distribution (AIC=889.3829), with which disease stage, type of therapy, and age were significant factors. Among the different types of therapy, chemotherapy and radiotherapy yielded higher survival rates, and increased age was associated with lower survival. CONCLUSION: The most efficient model was a log-normal model. Implementation of optimal therapies at early stages can improve the survival of patients.